Dan Lemaitre

Track

Insider profile

Currently holds positions in Endologix Inc and Globus Medical Inc

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -1% 8.2% 15.1%
Success rate 42% 68% 82%
Transactions
7 29% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chairman of the Board Endologix Inc Feb. 6, 2017 -
Independent Director Globus Medical Inc April 1, 2011 -
Lead Independent Director Endologix Inc March 1, 2014 - Feb. 6, 2017
Independent Director Endologix Inc Dec. 11, 2009 - March 1, 2014
Dan Lemaitre's trades of Globus Medical Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Sale
Price
128.48
Quantity 78,191 +25.7%
Value US$4,610,096
Transaction date
Sale
Price
165.15
Quantity 58,175 +21.8%
Value US$4,539,044
Transaction date
Proposed sale
Price
483.59
Quantity 36,093
Value US$3,749,795
Transaction date
Sale
Price
64.61
Quantity 63,300 -100.0%
Value US$4,090,022
Transaction date
Proposed sale
Price
64.50
Quantity 52,500
Value US$3,386,250
Transaction date
Proposed sale
Price
64.24
Quantity 10,800
Value US$693,777
Transaction date
Sale
Price
56.98
Quantity 43,450 -80.1%
Value US$2,475,977
Transaction date
Proposed sale
Price
56.93
Quantity 43,450
Value US$2,473,775
Transaction date
Sale
Price
62.47
Quantity 15,384 -100.0%
Value US$961,038
US Endologix Inc (ELGX)
Transaction date
Sale
Price
0.05
Quantity 15,553 -100.0%
Value US$810
US Endologix Inc (ELGX)
Transaction date
Sale
Price
0.05
Quantity 33,709 -68.4%
Value US$1,689
US Endologix Inc (ELGX)
Transaction date
Sale
Price
0.05
Quantity 2,582 -5.0%
Value US$129
US Endologix Inc (ELGX)
Transaction date
Sale
Price
0.08
Quantity 1,127 -2.1%
Value US$92
US Endologix Inc (ELGX)
Transaction date
Sale
Price
0.09
Quantity 1,126 -2.1%
Value US$98
Transaction date
Purchase
Price
1.34
Quantity 7,500
Value £10,044
Transaction date
Purchase
Price
2.14
Quantity 6,000
Value £12,828
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-11-25 2024-11-22
S Sale
78,191 +25.7%
128.48
US$4,610,096 		78,191 +25.7% 128.48 US$4,610,096
2024-11-25 2024-11-21
S Sale
58,175 +21.8%
165.15
US$4,539,044 		58,175 +21.8% 165.15 US$4,539,044
2024-11-21 2024-11-21
PrS Proposed sale
36,093
483.59
US$3,749,795 		36,093 483.59 US$3,749,795
2024-05-14 2024-05-10
S Sale
63,300 -100.0%
64.61
US$4,090,022 		63,300 -100.0% 64.61 US$4,090,022
2024-05-10 2024-05-10
PrS Proposed sale
52,500
64.50
US$3,386,250 		52,500 64.50 US$3,386,250
2024-05-10 2024-05-10
PrS Proposed sale
10,800
64.24
US$693,777 		10,800 64.24 US$693,777
2023-05-17 2023-05-15
S Sale
43,450 -80.1%
56.98
US$2,475,977 		43,450 -80.1% 56.98 US$2,475,977
2023-05-16 2023-05-15
PrS Proposed sale
43,450
56.93
US$2,473,775 		43,450 56.93 US$2,473,775
2021-03-11 2021-03-09
S Sale
15,384 -100.0%
62.47
US$961,038 		15,384 -100.0% 62.47 US$961,038
2020-09-17 2020-09-04
US Endologix Inc (ELGX)
S Sale
15,553 -100.0%
0.05
US$810 		15,553 -100.0% 0.05 US$810
2020-09-17 2020-09-04
US Endologix Inc (ELGX)
S Sale
33,709 -68.4%
0.05
US$1,689 		33,709 -68.4% 0.05 US$1,689
2020-09-17 2020-09-04
US Endologix Inc (ELGX)
S Sale
2,582 -5.0%
0.05
US$129 		2,582 -5.0% 0.05 US$129
2020-08-19 2020-08-14
US Endologix Inc (ELGX)
S Sale
1,127 -2.1%
0.08
US$92 		1,127 -2.1% 0.08 US$92
2020-08-19 2020-08-13
US Endologix Inc (ELGX)
S Sale
1,126 -2.1%
0.09
US$98 		1,126 -2.1% 0.09 US$98
2020-01-27 2020-01-23
B Purchase
7,500
1.34
£10,044 		7,500 1.34 £10,044
2018-11-02 2018-10-31
B Purchase
6,000
2.14
£12,828 		6,000 2.14 £12,828